This compound, 2-Cyano-4-(3-methylpiperidin-1-yl)phenylboronic acid, is primarily utilized in the field of organic synthesis, particularly in cross-coupling reactions. It serves as a key intermediate in the production of various pharmaceuticals, enabling the formation of complex molecular structures through Suzuki-Miyaura coupling. Its boronic acid group facilitates the creation of carbon-carbon bonds, making it valuable in the synthesis of biologically active compounds. The cyano group at position 2 and the 3-methylpiperidin-1-yl substituent at position 4 enhance its potential for binding to biological targets, such as enzymes or receptors. Additionally, it is employed in the development of potential therapeutic agents in medicinal chemistry research. The compound’s stability and reactivity make it a versatile tool in drug discovery and development processes.